Loading organizations...
§ Private Profile · Seattle, WA, USA
Investment firm (auto-created from funding round data)
Privateer Holdings is a private equity firm that strategically invests in and builds brands within the legal cannabis industry. The firm provides capital and operational expertise to businesses aiming to normalize and mainstream cannabis consumption, focusing on developing high-quality, reputable products and services in this evolving sector.
Founded on October 20, 2011, by Brendan Kennedy, Michael Blue, and Chris Groh, Privateer Holdings was established on the insight that cannabis would inevitably transition into a mainstream consumer product. The founders sought to legitimize the nascent market by attracting institutional investment and applying traditional business principles.
Privateer Holdings acts as a capital partner for diverse cannabis enterprises, from cultivation to retail. Its long-term vision centers on fostering a responsible, regulated global cannabis market, positioning the plant as a widely accepted consumer good. The firm aims to shape the industry's future by backing companies prioritizing professionalism and consumer trust.
Privateer Holdings has raised $182.0M across 3 funding rounds.
Privateer Holdings has raised $182.0M in total across 3 funding rounds.
Privateer Holdings has raised $182.0M across 3 funding rounds. Most recently, it raised $100.0M Series C in January 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 1, 2018 | $100M Series C | — | Endeavor Health Ventures | Announced |
| Apr 1, 2015 | $75M Series B | Geoff Lewis | AME Cloud Ventures, B Capital Group, Bedrock Capital, David Namdar, Greylock, Hardware Club, Khosla Ventures, Morado Venture Partners, NEO, OS Fund, Bart Swanson, Hadi Partovi, Kevin Colas, Marc Benioff, Scott Banister | Announced |
| Jan 1, 2013 | $7M Series A | — | Endeavor Health Ventures | Announced |
Privateer Holdings has raised $182.0M in total across 3 funding rounds.
Privateer Holdings's investors include Endeavor Health Ventures, Geoff Lewis, AME Cloud Ventures, B Capital Group, Bedrock Capital, David Namdar, Greylock, Hardware Club, Khosla Ventures, Morado Venture Partners, NEO, OS Fund.
Privateer Holdings is a Seattle-based private equity firm founded to shape the future of the legal cannabis industry through investments in mainstream brands and companies.[1][2][3][4] Its mission centers on three core beliefs: cannabis as a mainstream product for everyday consumers, the inevitability of ending cannabis prohibition, and the pivotal role of brands in defining the industry's future.[2] The firm's investment philosophy emphasizes professionalizing cannabis businesses via strategic acquisitions, incubations, and 100% ownership of portfolio companies, targeting the global legal cannabis market.[1][2][4] Key sectors include cannabis production, distribution, retail platforms, and consumer brands, with notable investments like Leafly (a cannabis information platform), Tilray (medical cannabis producer), and Marley Natural (lifestyle brand).[1]
Privateer has significantly impacted the startup ecosystem by securing the first institutional investor in cannabis—Founders Fund—and pioneering milestones such as Leafly's 2014 New York Times ad and Tilray's exports to Australia, Brazil, and Europe, legitimizing the sector amid regulatory evolution.[1][2]
Privateer Holdings was founded on October 20, 2011, by Brendan Kennedy, Michael Blue, and Chris Groh—three entrepreneurs with prior experience in financial services and strategic consulting.[1][2][3] The trio launched the firm in Seattle amid early U.S. state-level cannabis legalization, aiming to build a portfolio of global brands in a nascent, prohibition-constrained market.[1][4] Key early moves included acquiring Leafly in 2011, investing in Tilray (a federally licensed Canadian medical cannabis producer), and partnering with the Bob Marley estate in 2014 for Marley Natural, which debuted products in 2016.[1]
The firm's evolution accelerated with regulatory shifts: by 2017-2018, it closed a $100+ million Series C round and expanded internationally, employing over 350 people across seven countries; in 2019, it merged with portfolio company Tilray, marking a pivotal consolidation amid booming market opportunities.[1][2]
Privateer rode the wave of cannabis legalization trends, starting with U.S. state reforms in 2011 and expanding to Canada's federal framework, positioning itself as a first-mover in a "rocketing" market projected for explosive growth.[1][2] Timing was critical: early entry amid prohibition's end allowed it to capitalize on regulatory openings, like Tilray's pioneering North American exports, while market forces—shifting public attitudes, medical demand, and global decriminalization—fueled portfolio expansion.[1]
The firm influenced the ecosystem by mainstreaming cannabis through branded, professional operations, attracting institutional capital, and demonstrating scalability in a controversial sector, paving the way for broader VC interest despite persistent federal risks in the U.S.[2][5]
Post-2019 Tilray merger, Privateer operates within a larger public entity, likely amplifying its global reach in medical and recreational cannabis amid ongoing legalization (e.g., U.S. federal reforms, EU expansions).[1] Trends like pharmaceutical-grade products, international exports, and branded consumer goods will shape its path, with potential for further M&A or IPO leverage in maturing markets.[1][2] Its influence may evolve from pioneer investor to integrated operator, defining cannabis as a legitimate trillion-dollar industry—echoing its founding thesis that brands will lead prohibition's end.[2][4]